General Information of Drug Transporter (DT)
DT ID DTD0227 Transporter Info
Gene Name SLC26A1
Transporter Name Sulfate anion transporter 1
Gene ID
10861
UniProt ID
Q9H2B4
Post-Translational Modification of This DT
Overview of SLC26A1 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-N-glycosylation X-Phosphorylation X: Amino Acid

N-glycosylation

  Asparagine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC26A1 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

158

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC26A1 Asparagine 158 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC26A1 [1]

Role of PTM

Potential impacts

Modified Residue

Asparagine

Modified Location

163

Experimental Method

Co-Immunoprecipitation

Detailed Description

N-linked Glycosylation at SLC26A1 Asparagine 163 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC26A1 [2]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

4

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC26A1 Serine 4 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC26A1 [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

500

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC26A1 Serine 500 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC26A1 [2] , [4]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

578

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC26A1 Serine 578 has the potential to affect its expression or activity.

  Threonine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC26A1 [2] , [4]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

580

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC26A1 Threonine 580 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC26A1 [2]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

598

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC26A1 Threonine 598 has the potential to affect its expression or activity.
References
1 dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: S26A1_HUMAN)
2 Identification of Missing Proteins in the Phosphoproteome of Kidney Cancer. J Proteome Res. 2017 Dec 1;16(12):4364-4373.
3 Ischemia in tumors induces early and sustained phosphorylation changes in stress kinase pathways but does not affect global protein levels. Mol Cell Proteomics. 2014 Jul;13(7):1690-704.
4 Non-alcoholic fatty liver disease phosphoproteomics: A functional piece of the precision puzzle. Hepatol Res. 2017 Dec;47(13):1469-1483.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.